Western Companies Moderna announced topline results from a Phase 3 pivotal trial evaluating mRNA-1647, an investigational cytomegalovirus (CMV) vaccine. The study did not meet its primary efficacy endpoint of preventing...
Western Companies Moderna (UK). Moderna has opened a new mRNA vaccine manufacturing facility in Oxfordshire, UK, with the capacity to produce approximately 100 million doses annually under steady-state conditions...
1. Pfizer (USA) and BioNTech (Germany) News: Pfizer and BioNTech have submitted a new application to the European Medicines Agency for a COVID-19 vaccine adapted to the 2025–2026 LP.8.1 strain. Pfizer and BioNTech...
Moderna, once celebrated for its rapid development of a lifesaving COVID-19 vaccine during the initial Trump administration, now finds itself navigating a dramatically changed landscape as the U.S. government tightens...
On May 21, 2025, Moderna, announced a significant update regarding its flu/COVID combination vaccine candidate, mRNA-1083. In consultation with the U.S. Food and Drug Administration (FDA), Moderna has voluntarily...
The mRNA-based COVID-19 vaccines made by Pfizer/BioNTech and Moderna have proven highly effective at priming our immune systems to fight the pandemic coronavirus—preventing substantial amounts of infection, severe...